MSI-H | MSS | |||||||
---|---|---|---|---|---|---|---|---|
SnoN Expression Level | SnoN Expression Level | |||||||
Total | Increased | No Change | Decreased | Total | Increased | No Change | ||
Total No. Patients | 18 | 6 | 5 | 7 | 34 | 17 | 17 | P < 0.001Δ |
Sex | ||||||||
Male | 6 | 2 | 1 | 3 | 21 | 9 | 12 | |
Female | 12 | 4 | 4 | 4 | 13 | 8 | 5 | |
Site | ||||||||
Proximal | 13 | 3 | 5 | 5 | 14 | 8 | 6 | |
Distal | 5 | 3 | 0 | 2 | 20 | 9 | 11 | |
ACPS Stage | ||||||||
A | 5 | 0 | 4 | 1 | 6 | 3 | 3 | |
B | 8 | 5 | 0 | 3 | 15 | 8 | 7 | |
C | 3 | 1 | 0 | 2 | 5 | 3 | 2 | |
D | 2 | 0 | 1 | 1 | 7 | 2 | 5 | |
Recurrence of Cancer in ACPS Stage A, B or C | 0 | 0 | 0 | 0 | 3 | 0 | 3 | P < 0.1• |
ACPS Stage D or Recurrence of Cancer in ACPS Stage A, B or C | 2 | 0 | 1 | 1 | 10 | 2 | 8 | P < 0.025◆ |